Cure TV

Dana Bushman, a certified yoga instructor, discusses her story and her connection to yoga.

Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses survivorship for patients with hereditary breast cancer.

Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses breast cancer survivorship.

Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses breast cancer survivorship.

Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the ABOUT Network and the importance of informed decision-making.

Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the ABOUT Network and the importance of informed decision-making.

Melanie A. Nix, co-founder of the Breast Cancer Comfort Site, discusses the various stages of advocacy.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.

Debu Tripathy, editor-in-chief of CURE and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses adding the targeted drug Ibrance to the hormonal drug Faslodex.

Colleen M. O'Leary, RN, MSN, AOCNS, from The James Cancer Hospital, The Ohio State University, discusses how patients can manage oral mucositis.

Patricia Carter, PhD, RN, CNS, associate professor, School of Nursing, The University of Texas at Austin, discusses the importance of sleep for patients with cancer.

Julie Fleshman, JD, MBA, president, CEO, Pancreatic Cancer Action Network, discusses the role of nutrition in the life of a patient with pancreatic cancer.

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the treatment of oral mucositis in patients with head and neck cancer.

Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, provides an overview of biomarkers in prostate cancer.

Anne Katz, RN, PhD, clinical nurse specialist, sexuality counselor, CancerCare Manitoba, discusses young patients with cancer and their sexuality.

Michael Ferraro, executive chef, Delicatessen, discusses his mother's journey with pancreatic cancer and his role in the Cooking. Comfort. Care. Nourishment for the Pancreatic Cancer Fight program.

Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.

Sandra Spoelstra, PhD, RN, Assistant Professor, College of Nursing, Michigan State University, discusses educating patients about oral agents.

Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses educating patients before they enroll on a clinic trial.

The Extraordinary Healer Award for Oncology Nursing recognizes nurses whose compassion, expertise and helpfulness have made an incredible impact on someone affected by cancer.

Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Bishoy M. Faltas, medical fellow at Weill Cornell Medical College, explains how the genomic landscape of bladder cancers has an impact on possible treatments for patients.

Oncologist Serena Wong, of Rutgers Cancer Institute of New Jersey, reassures patients suffering from cognitive dysfunction, or chemobrain, that they're not alone and there is support.

Michelle Gervino, an oncology nurse with John Theurer Cancer Center, discusses the importance of caregivers, as well as resources for both caregivers and patients.

Surgery has its side effects, says radiation oncologist Richard Stock, including possible incontinence and sexual dysfunction. While radiation is less invasive, it does have its own side effects.

James Battiste, an oncologist with Stephenson Cancer Center in Oklahoma City, Okla., says patients with glioblastoma will likely have a lot of questions about the diagnosis.

Kevin B. Kim, of the California Pacific Medical Center, explains how patients with melanoma who are in remission can get back into a normal, daily routine while still taking precautions.

At age 22, Megan Miller was diagnosed with basal cell carcinoma, a common form of skin cancer that can be easily treated. But a year later, she was diagnosed with melanoma.